Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Irrisept OR Recalled by Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company Due to Lack of sterility assurance: leaking containers which could...

Date: September 5, 2017
Company: Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company directly.

Affected Products

Irrisept OR, Finished Bottle Assembly 450 ml STEP 1

Quantity: 10,440

Why Was This Recalled?

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Where Was This Sold?

This product was distributed to 36 states: AZ, CA, CO, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NY, NC, OH, OR, PA, SC, TN, TX, UT, VT, VA, WA, WI

Affected (36 states)Not affected

About Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company

Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company has 18 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report